Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
F. HOFFMANN-LA ROCHE LTD and its Affiliates

2. Address

Address1
1425 K STREET, NW, #650
 Address2
​
City
WASHINGTON
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
 State
​
 Zip Code
​
 Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mrs.
​SHANNON C. STEWARD
​2024080090
​shannon.cottrell-steward@roche.com
5. Senate ID#
​18411-12
7. Client Name Self Check if client is a state or local government or instrumentality
​F. HOFFMANN-LA ROCHE LTD and its Affiliates
6. House ID#
​311670000
TYPE OF REPORT 8. Year
​2009
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
 11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​1,042,123.70
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Evan Morris, Vice President Government Affairs
 Date
01/19/2010

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Issues related to government purchases of pandemic drugs, Tamiflu

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Darin
Gardner
​
Director, Federal Government Affairs

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Advocate on legislative changes regarding biosimilars; pandemic preparedness, health reform, health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics; policy analysis; address concerns regarding the federal government's purchase and stockpiling of Tamiflu; HR 3200 America's Affordable Health Choices Act: and the America's Healthy Future Act of 2009; H.R. 1 - Pandemic influenza funding; H.R. 1105 Omnibus Appropriations Act; Pandemic funding issues;
FY10 Labor HHS Appropriations legislation: H.R. 2346 Supplemental Appropriations Act of 2009 Congress and Federal Agencies; community relations and outreach to develop and maintain relationships with minority groups and health organizations; Public policy such as developming strategies on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Darin
Gardner
​
Director, Federal Government Affairs
Anna
Sagely
​
Director, Federal Government Affairs
Evan
Morris
​
Vice President, Federal Government Affairs
Katherine
Martin
​
Director, Federal Government Affairs
Kathleen
Claessens
​
Director, Roche Diagnostics
Thomas
Barnett
​
Director, Roche Diagnostics
Bruce
Taylor
​
Director, Roche Diagnostics

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HOM

16. Specific lobbying issues

Labor HHS Appropriations - S. 3230 and H.R. 3042, Homeland Security Appropriations S3181 and H.R. 6947 Congress and Federal Agencies

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Office of Personnel Management (OPM), Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Darin
Gardner
​
Director, Federal Government Affairs

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
 State
​
 Zip Code
​
 Country
​

21. Client new principal place of business (if different than line 20)

City
​
 State
​
 Zip Code
​
 Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6